Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture

The emerging SARS-CoV-2 infection associated with the outbreak of viral pneumonia in China is ongoing worldwide. There are no approved antiviral therapies to treat this viral disease. Here we examined the antiviral abilities of three broad-spectrum antiviral compounds gemcitabine, lycorine and oxyso...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Ya-Nan Zhang, Qiu-Yan Zhang, Xiao-Dan Li, Jin Xiong, Shu-Qi Xiao, Zhen Wang, Zhe-Rui Zhang, Cheng-Lin Deng, Xing-Lou Yang, Hong-Ping Wei, Zhi-Ming Yuan, Han-Qing Ye, Bo Zhang
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Taylor & Francis Group 2020-01-01
Reeks:	Emerging Microbes and Infections
Onderwerpen:	Novel coronavirus alkaloid broad-spectrum antiviral 2019-nCoV SARS-CoV-2
Online toegang:	https://www.tandfonline.com/doi/10.1080/22221751.2020.1772676
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!